The Latest Breaking News on Pharma

Nirvana Life Sciences Inc. (CSE: NIRV) announced that it has engineered a method that reduces the manufacturing time of MDMA by two thirds.

Amylyx Pharmaceuticals Inc.’s controversial treatment for amyotrophic lateral sclerosis won the support of a panel of U.S. regulatory advisers, putting the product on track for likely clearance.

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

Even with new boosters, experts predict the scourge that’s already lasted longer than the 1918 flu pandemic will linger far into the future. Here’s why.

The Food and Drug Administration is holding an unusual second meeting to review a closely watched drug for the illness known as Lou Gehrig’s disease

E-cigarette producer Juul Labs agreed to pay $438.5 million to 34 states and territories to sort out a two-year bipartisan investigation into its marketing and sales practices.

Billionaire investor and Dallas Mavericks owner Mark Cuban, who has revolutionized healthcare with his “Cost Plus Drug Company,” has taken inspiration from someone who is an antithesis of sorts, the Shark Tank investor revealed to Re

A research study published in The Lancet has talked about one of the most serious habits of Indians which should have been talked about earlier. The study says close to 50% of the antibiotic formulations used in India's private sector in 2019 were not approved by the central drug regulator.

The Leeds-based creator of regenerative medical devices increased revenues across the first half of 2022